.png?width=3840&quality=75&resize=contain)
CDMO
Serán Bioscience Announces $200 Million Strategic Growth Transaction and Plans for New Commercial Facility
Serán Bioscience
PR-09-24-NI-07Sep 17, 2024
IPO
Kairos Pharma Prices $6.2 Million Initial Public Offering
Kairos Pharma Ltd.
PR-09-24-NI-05Sep 16, 2024
Digitalization
Radical Bioprocessing Efficiencies and Cost Reductions — The Next Wave of Biopharmaceutical Innovation
Michael Sokolov, Ph.D.
DataHow
PAO-08-24-CL-02Aug 26, 2024
Investment
What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?
Pharma's Almanac
PAO-06-24-RT-01Jun 24, 2024
Training
Biotech Training is a Challenge
April Stanley, MS MBA; Koey Keylon
Nice Insight
PAO-06-24-NI-01Jun 11, 2024
Supply Chain
Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience
Tim Tyson; Jesse McCool, Ph.D.; Russell Harris; Yongkwan Ma
TriRx Pharmaceutical Services
PTV-12-23-CL-02Dec 12, 2023
Expansion
Vetter looks ahead to further expansions to meet supply chain demand
Vetter Pharma International GmbH
PR-M10-23-03Oct 17, 2023
Business Leadership
Wheeler Bio Appoints Marc Helouin as Chief Quality and Regulatory Officer
Wheeler Bio
PR-M08-23-01Aug 15, 2023
Brand Relaunch
Techceuticals Announces Relaunch with an Expanded Focus on the Pharmaceutical Industry
Techceuticals
PR-M04-23-02Apr 25, 2023
Vantage Nutrition LLC Acquires ComboCap Inc
Vantage Solutions
PR-M03-23-07Mar 27, 2023
mRNA Manufacturing
Investing in the Future of mRNA Manufacturing
Esther Yoo, Ph.D.
Samsung Biologics
PAO-11-022-CL-02Nov 16, 2022
Investment
Orgenesis Secures up to USD 50 Million Subsidiary-Level Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Services
Orgenesis
PR-M11-22-05Nov 07, 2022
Warehouse Storage
New Fully Automated Vetter Warehouse Expands Storage and Boosts Logistical Infrastructure
Vetter Pharma International GmbH
PR-M10-22-07Oct 27, 2022
Series A Funding
Wheeler Bio Announces Initial Closing of Series A Round Supporting New Biologics Drug Substance GMP Expansion In Oklahoma
Wheeler Bio
PR-M10-22-02Oct 05, 2022
Business Leadership
Olon Announces the Appointment of Roberta Pachera as Vice President of CDMO Small Molecules and Global Key Account Division
Olon
PR-M09-22-04Sep 19, 2022
Manufacturing Investment
MilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France
MilliporeSigma
PR-M09-22-02Sep 08, 2022
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio
PR-M09-22-01Sep 07, 2022
Cosmeceuticals
Cosmeceuticals Are Here. When Will Regulations Catch Up?
Ameena Pathan
That's Nice LLC
PAO-08-022-CL-09Aug 31, 2022
New Project Funding
NIIMBL Announces $15.8M to Fund 14 New Biopharmaceutical Manufacturing Projects
NIIMBL
PR-M08-22-02-279Aug 09, 2022
New Division
Olon Presents Olon Biotech, A New Division Operating by Biotechnological Processes
Olon
PR-M07-22-03Jul 12, 2022